Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

Abstract

Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved.

Keywords

• Rosuvastatin
• cardiovascular events
• patients
• undergoing hemodialysis
• myocardial infarction
• death
• cholesterol level